OBIO Competitors & Alternatives
Compare Orchestra BioMed Holdings Inc. with similar stocks in the same industry
Biotechnology
OBIO
Main Stock$3.92
Tradestie Score
55
Market Cap
$137.59M
Revenue Growth
-0.9%
Analyst Upside
+210.4%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.10
|
$275.13M | - | 58 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.75
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.51
|
$262.67M | - | 59 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$9.81
|
$258.18M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$42.84
|
$256.54M | - | 65 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$2.24
|
$231.77M | - | 55 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.12
|
$211.28M | - | 58 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$13.51
|
$211.22M | - | 57 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.71
|
$202.58M | - | 58 | Compare |
More OBIO Analysis
Data updated: Jul 10, 2026 | Industry: Biotechnology (SIC 3841)
239 stocks in this industry